Sinusitis is a common medical disease with a tremendous economic impact on health care. Our objective was to determine the most cost-effective strategy for the management of acute sinusitis from the societal and payers’ perspectives.
Methods
A Markov disease simulation model was used for comparing four treatment strategies: (1) no antibiotic (Abx), (2) empiric Abx, (3) CT-based Abx, and (4) clinical guideline-based Abx.
Results
Empiric Abx treatment was the most cost-effective from the societal perspective. Clinical guideline-based treatment was the most cost-effective strategy from the payers’ perspective ($38,515/quality-adjusted life year). Cost and effectiveness of Abx, time lost from work, and prevalence of acute bacterial sinusitis are influential variables.
Conclusion
Empiric Abx treatment is a cost-effective strategy from the short-term societal perspective. However, Abx resistance will lead to increased costs and reduced efficacy of this strategy in the long-term. Clinical guidelines provide a low-cost method of targeting therapy.
WillettL.R., CarsonJ.L., and WilliamsJ.W.Jr.Current diagnosis and management of sinusitis.J Gen Intern Med9: 38–45, 1994.
2.
LauJ., ZuckerD., EngelsE.A.Diagnosis and treatment of acute bacterial rhinosinusitis.In Evidence Report/Technology Assessment, Vol. 9. Rockville, MD: Agency for Health Care Policy and Research,1–18, 1999.
3.
KalinerM.A., OsguthorpeJ.D., FiremanP.Sinusitis: Bench to bedside: Current findings, future directions.Otolaryngol Head Neck Surg (suppl) 116: 1–20, 1997.
4.
GwaltneyJ.M.Jr., ScheldW.M., SandeM.A.The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: A fifteen-year experience at the University of Virginia and review of other selected studies.J Allergy Clin Immunol90: 457–461, 1992.
5.
HicknerJ.M., BartlettJ.G., BesserR.E.Principles of appropriate antibiotic use for acute rhinosinusitis in adults: Background.Ann Emerg Med37: 703–710, 2001.
6.
SnowV., Mottur-PilsonC., HicknerJ.M.Principles of appropriate antibiotic use for acute sinusitis in adults. Clinical practice guideline, Part 1.Ann Intern Med134: 495–497, 2001.
7.
McCaigL.F., and HughesJ.M.Trends in antimicrobial drug prescribing among office-based physicians in the United States.JAMA273: 214–219, 1995.
8.
DowellS.F., SchwartzB., and PhillipsW.R.Appropriate use of antibiotics for URIs in children: Part I. Otitis media and acute sinusitis. The Pediatric URI Consensus Team.Am Fam Physician58: 1113–1118, 1123, 1998.
9.
LiuY.C., HuangW.K., HuangT.S.Inappropriate use of antibiotics and the risk for delayed admission and masked diagnosis of infectious diseases: A lesson from Taiwan.Arch Intern Med161: 2366–2370, 2001.
10.
CohenM.L.Epidemiology of drug resistance: Implications for a post-antimicrobial era.Science257: 1050–1055, 1992.
LindbaekM., HjortdahlP., and JohnsenU.L.Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults.BMJ313: 325–329, 1996.
13.
LowD.E., DesrosiersM., McSherryJ.A practical guide for the diagnosis and treatment of acute sinusitis.CMAJ156(suppl 6): S1–S14, 1997.
14.
LindbaekM.Acute sinusitis: Guide to selection of antibacterial therapy.Drugs64: 809–819, 2004.
15.
BriggsA., and SculpherM.An introduction to Markov modelling for economic evaluation.Pharmacoeconomics13: 397–409, 1998.
16.
IoannidisJ.P., and LauJ.Technical report: Evidence for the diagnosis and treatment of acute uncomplicated sinusitis in children: A systematic overview.Pediatrics108: E57, 2001.
17.
ClementP.A., BluestoneC.D., GordtsF.Management of rhinosinusitis in children.Int J Pediatr Otorhinolaryngol49(suppl 1): S95–S100, 1999.
18.
GarbuttJ.M., GoldsteinM., GellmanE.A randomized, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis.Pediatrics107: 619–625, 2001.
19.
WilliamsJ.W.Jr., SimelD.L., RobertsL.Clinical evaluation for sinusitis. Making the diagnosis by history and physical examination.Ann Intern Med117: 705–710, 1992.
20.
van BuchemL., PeetersM., BeaumontJ., and KnottnerusJ.A.Acute maxillary sinusitis in general practice. The relation between clinical picture and objective findings.Eur J Gen Pract1: 155–160, 1995.
21.
SokolW.Epidemiology of sinusitis in the primary care setting: Results from the 1999–2000 respiratory surveillance program.Am J Med111(suppl 9A): 19S–24S, 2001
22.
VaronenH., MakelaM., SavolainenS.Comparison of ultrasound, radiography, and clinical examination in the diagnosis of acute maxillary sinusitis: A systemic review.J Clin Epidemiol53: 940–948, 2000.
23.
PiccirilloJ.F., MagerD.E., FrisseM.E.Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis.JAMA286: 1849–1856, 2001.
24.
AnzaiY., HollingworthW., and JarvikJ.G.Measurement of health burden of acute sinusitis. AUR/RAHSR meeting, Scientific Presentation. Elsevier, Montreal, May 2005.
25.
EngelsE.A., TerrinN., BarzaM., and LauJ.Meta-analysis of diagnostic tests for acute sinusitis.J Clin Epidemiol53: 852–862, 2000.
26.
GwaltneyJ.M.Jr., PhyillipsC.D., MillerR.D., and RikerD.K.Computed tomographic study of the common cold.N Engl J Med330: 25–30, 1994.
27.
BurkeT.F., GuertlerA.T., and TimmonsJ.H.Comparison of sinus x-rays with computed tomography scans in acute sinusitis.Acad Emerg Med1: 235–239, 1994.
28.
LaineK., MaattaT., VaronenH., and MakelaM.Diagnosing acute maxillary sinusitis in primary care: A comparison of ultrasound, clinical examination, and radiology.Rhinology36: 2–6, 1998.
29.
GwaltneyJ.M.Jr., SydnorA.Jr., and SandeM.A.Etiology and antimicrobial treatment of acute sinusitis.Ann Otol Rhinol Laryngol Suppl90: 68–71, 1981.
30.
van BuchemF.L., KnottnerusJ.A., SchrijnemaekersV.J., and PeetersM.F.Primary care based randomized placebo-controlled trial of antibiotic treatment in acute maxilalry sinusitis.Lancet349: 683–687, 1997.
31.
VaronenH., KunnamoI., SavolainenS.Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care.Scand J Prim Health Care21: 121–126, 2003.
32.
BucherH.C.Effect of amoxicillin-clavulanate in clinically diagnosed acute rhnosinusitis: A placebo-controlled, double blinded, randomized trail in general practice.Arch Intern Med163: 1793–1798, 2003.
33.
GoldM.R., PatrickD.L., TorranceG.W.Identifying and validating outcomes. In Cost-Effectiveness in Health and Medicine.SiegelJ.E., RussellL.B., WeinsteinM.C., and GoldM.R. (Eds). Oxford University Press, Oxford, UK.82–134, 1997.
34.
FurlongW.J., FreenyD.H., TorranceG.W., and BarrB.D.The health utilities inbdex (HUI) system for assessing health related quality of life in clinical studies.Ann Med33: 375–372, 2001.
ZhangR., EgglestonK., RotimiV., and ZeckhauserR.J.Antibiotic resistance as a global threat: Evience from China, Kuwait, and the United States.Global Health2: 6, 2006. (Online publication: www.globalizationandhealth.com/content/2/1/6.)
37.
DowellS.F., and SchwartzB.Resistant pneumococci: Protecting patients through judicious use of antibiotics.Am Fam Physician55: 1647–1654, 1997.
38.
GonzalezR., MalineD.C., MaselliJ.H., and SandeM.A.Excessive antibiotic use for acute respiratory infections in the United States.Clin Infect Dis33: 757–762, 2001.
39.
BalkE.M., ZuckerD.R., EngelsE.A.Strategies for diagnosing and treating suspected acute bacterial sinusitis: A cost-effectiveness analysis.J Gen Intern Med16: 701–711, 2001.
